Healthtech Investors & VC Firms in Europe

191 firms in this list, with a median first check of $635K. 20 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
TH Think.Health FKMRNB3 people	88🔒	Berlin	DE	Seed–Growth	$545K – $10.9M	+ Add to CRM
AM Amboy Street Ventures CSCFSR3 people	88🔒	Venice	US	Seed–Series A	—	+ Add to CRM
AC Acrew Capital TGAKLKMK9 people	88🔒	San Francisco	US	Seed–Series B	$1M – $15M	+ Add to CRM
OV Overwater Ventures Llc KS1 person · Leads rounds	88🔒	Palo Alto	US	Pre-Seed–Series A	$500K – $2M	+ Add to CRM
KI Kinnevik	88🔒	Stockholm	SE	Series A–Late Stage	—	+ Add to CRM
TR Treo Ventures, Llc MJBHMKTP4 people	88🔒	Minneapolis	US	Seed–Late Stage	—	+ Add to CRM
RE Revent HGLLOBRB5 people	88🔒	Berlin	DE	Seed–Series A	$216K – $2.2M	+ Add to CRM
SB SBVA CJJDJCJL11 people	88🔒	Seoul	KR	Seed–Series B	$1M – $2.5M	+ Add to CRM
AT Atlantic Vantage Point ASBFDMFR11 people	88🔒	Paris	FR	Seed–Late Stage	$1M – $20M	+ Add to CRM
AV Avant Bio DKLUMWOH5 people · Leads rounds	88🔒	New York	US	Seed–Growth	—	+ Add to CRM
B2 b2venture FSAGCSGJ11 people	88🔒	Berlin	DE	Pre-Seed–Late Stage	$270K – $5.4M	+ Add to CRM
FR Frazier Healthcare Partners BMBKCRKB11 people	88🔒	Seattle	US	Growth	$50M – $400M	+ Add to CRM
GI Gilde Healthcare AFEDGPHD11 people	88🔒	Utrecht	NL	Seed–Late Stage	$1.1M – $32.4M	+ Add to CRM
HE Hercules Capital, Inc. BJCJGPJB11 people	88🔒	San Mateo	US	Seed–Late Stage	$500K – $50M	+ Add to CRM
IM Impact Fund Denmark ADLEOVAP11 people	88🔒	Copenhagen K	DK	Seed–Late Stage	$2.2M – $70.2M	+ Add to CRM
JJ JJDC FMHPLTTM11 people	88🔒	New Brunswick	US	Seed–Series B	$500K – $5M	+ Add to CRM
MC MCI Capital S.A. EOFBMGPS11 people	88🔒	Warsaw	PL	Growth	$27M – $108M	+ Add to CRM
MV MVM Life Science Partners APEBEFHH11 people	88🔒	Boston	US	Seed–Late Stage	$3.8M	+ Add to CRM
NO Norrsken VC NAAFADDF11 people	88🔒	Stockholm	SE	Seed–Series A	$1.1M – $3.2M	+ Add to CRM
PA PAI Partners RVSDAKBM11 people	88🔒	Paris	FR	—	$108M – $324M	+ Add to CRM
TA Talde Private Equity IBJAMBAM11 people	88🔒	Bilbao	ES	Growth	$5.4M – $16.2M	+ Add to CRM
UN Unilever Ventures AOOGPCRH11 people	88🔒	London	GB	Seed–Late Stage	$540K – $10.8M	+ Add to CRM
VI Viola Credit AGEFIVNM11 people	88🔒	Tel Aviv	IL	Growth–Late Stage	$2M – $50M	+ Add to CRM
WO World Innovation Lab (WiL) MMAKGIRT11 people	88🔒	Tokyo	JP	Seed–Late Stage	$5M – $30M	+ Add to CRM

Think.Health

BerlinSeed–Growth$545K – $10.9M

FKMRNB3 people

Amboy Street Ventures

VeniceSeed–Series A

CSCFSR3 people

Acrew Capital

San FranciscoSeed–Series B$1M – $15M

TGAKLKMK9 people

Overwater Ventures Llc

Palo AltoPre-Seed–Series A$500K – $2M

KS1 person

Kinnevik

StockholmSeries A–Late Stage

Treo Ventures, Llc

MinneapolisSeed–Late Stage

MJBHMKTP4 people

Revent

BerlinSeed–Series A$216K – $2.2M

HGLLOBRB5 people

SBVA

SeoulSeed–Series B$1M – $2.5M

CJJDJCJL11 people

Atlantic Vantage Point

ParisSeed–Late Stage$1M – $20M

ASBFDMFR11 people

Avant Bio

New YorkSeed–Growth

DKLUMWOH5 people

b2venture

BerlinPre-Seed–Late Stage$270K – $5.4M

FSAGCSGJ11 people

Frazier Healthcare Partners

SeattleGrowth$50M – $400M

BMBKCRKB11 people

Gilde Healthcare

UtrechtSeed–Late Stage$1.1M – $32.4M

AFEDGPHD11 people

Hercules Capital, Inc.

San MateoSeed–Late Stage$500K – $50M

BJCJGPJB11 people

Impact Fund Denmark

Copenhagen KSeed–Late Stage$2.2M – $70.2M

ADLEOVAP11 people

JJDC

New BrunswickSeed–Series B$500K – $5M

FMHPLTTM11 people

MCI Capital S.A.

WarsawGrowth$27M – $108M

EOFBMGPS11 people

MVM Life Science Partners

BostonSeed–Late Stage$3.8M

APEBEFHH11 people

Norrsken VC

StockholmSeed–Series A$1.1M – $3.2M

NAAFADDF11 people

PAI Partners

Paris$108M – $324M

RVSDAKBM11 people

Talde Private Equity

BilbaoGrowth$5.4M – $16.2M

IBJAMBAM11 people

Unilever Ventures

LondonSeed–Late Stage$540K – $10.8M

AOOGPCRH11 people

Viola Credit

Tel AvivGrowth–Late Stage$2M – $50M

AGEFIVNM11 people

World Innovation Lab (WiL)

TokyoSeed–Late Stage$5M – $30M

MMAKGIRT11 people

Data sourced from public filings and firms' own websites — see our methodology.